medRxiv
Uptake and Safety Profile of Anti-Amyloid Immunotherapies in Routine Clinical Practice
Publication
, Preprint
Lusk, J; Fitch, KV; Johnson, K; Liu, A; Lund, J; Thomas, L; McDevitt, R; Zhao, A; Whitson, H; O’Brien, R; Aymes, S; Hammill, B; Mac Grory, B ...
2025
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Lusk, J., Fitch, K. V., Johnson, K., Liu, A., Lund, J., Thomas, L., … O’Brien, E. (2025). Uptake and Safety Profile of Anti-Amyloid Immunotherapies in Routine Clinical Practice. medRxiv. https://doi.org/10.1101/2025.09.11.25335562
Lusk, Jay, Kate Vinita Fitch, Kim Johnson, Andy Liu, Jennifer Lund, Laine Thomas, Ryan McDevitt, et al. “Uptake and Safety Profile of Anti-Amyloid Immunotherapies in Routine Clinical Practice.” MedRxiv, 2025. https://doi.org/10.1101/2025.09.11.25335562.
Lusk J, Fitch KV, Johnson K, Liu A, Lund J, Thomas L, et al. Uptake and Safety Profile of Anti-Amyloid Immunotherapies in Routine Clinical Practice. medRxiv. 2025.
Lusk, Jay, et al. “Uptake and Safety Profile of Anti-Amyloid Immunotherapies in Routine Clinical Practice.” MedRxiv, 2025. Epmc, doi:10.1101/2025.09.11.25335562.
Lusk J, Fitch KV, Johnson K, Liu A, Lund J, Thomas L, McDevitt R, Zhao A, Whitson H, O’Brien R, Aymes S, Hammill B, Mac Grory B, Li F, O’Brien E. Uptake and Safety Profile of Anti-Amyloid Immunotherapies in Routine Clinical Practice. medRxiv. 2025.